"SafeRide is a trusted Fresenius Medical Care partner and serves as our logistics backbone for a growing portion of our patient population. Access to care is foundational to 21st century healthcare and SafeRide is driving a new model for health systems, health plans and payors across the country."
CULVER CITY, Calif. (PRWEB) February 20, 2019
SafeRide, Inc. (“SafeRide Health;” “SafeRide”), a Los Angeles area-based healthcare logistics provider, announced that it has raised an undisclosed Series A equity financing round. Fresenius Medical Care Ventures led the round, with additional contributions from Amplify.LA, Bonfire Ventures, FCA Venture Partners, and Meridian Street Capital.
Fresenius Medical Care operates a global network of more than 3,800 dialysis clinics and partners with SafeRide to manage transportation benefits for a portion of their patients in the United States. On the investment Al Wiegman, Head of Fresenius Medical Ventures, notes, "SafeRide is a trusted Fresenius Medical Care partner and serves as our logistics backbone for a growing portion of our patient population. Access to care is foundational to 21st century healthcare and SafeRide is driving a new model for health systems, health plans and payors across the country. We are excited to support SafeRide's vision."
Robbins Schrader, CEO of SafeRide Health, adds, "Fresenius Medical Care manages the largest at-risk dialysis population worldwide. In the United States dialysis alone is nearly 2% of total GDP. As healthcare shifts to value-based care we're thrilled to learn and grow with the industry leader."
SafeRide works with medically qualified transport operators and preferred partners, like Lyft, to increase access to care. "Lyft and SafeRide share the vision of improving access to care,” says Gyre Renwick, Vice President of Lyft Business. “SafeRide seamlessly connects to Lyft's API and then delivers a suite of services to facilitate access to care for some of the nation's most challenging and at-risk populations. Together we're working to connect patients to the care they need."
SafeRide's Series A funding accelerates their software and logistics services offerings for health systems, health plans and payors, a $15Bn market opportunity. Health plans across the country use SafeRide’s fully-integrated solution and services to manage every aspect of their transportation programs. SafeRide integrates all stakeholders onto one software platform to seamlessly automate compliance, benefit management and pre-authorization. SafeRide then leverages its proprietary technology to deliver on-demand and scheduled multi-modal transport for all members ranging from mass transit, to rideshare, to medically qualified transport. The patient is the center of the experience and is carefully engaged to increase treatment compliance and deliver a world class experience. SafeRide ensures compliance, reduces cost, and transforms the patient experience.
About SafeRide Health:
SafeRide Health is a venture-backed startup founded in 2016 with the mission of improving access to care for the nation’s underserved populations. The SafeRide platform fulfills over 1 million rides per year by managing transportation programs for healthcare systems and states. SafeRide simplifies health system operations, improves patient outcomes, and reduces costs for some of the nation’s leading healthcare systems. Learn more at http://www.saferidehealth.com.
About Fresenius Medical Care Ventures GmbH:
Fresenius Medical Care Ventures was established to invest in start-ups and early-stage companies in the healthcare sector. The investments are targeted to support Fresenius Medical Care’s corporate strategy to grow continuously in the company’s core business and to expand into new business areas. Fresenius Medical Care Ventures complements its corporate innovation initiatives by external innovation. For more information, visit http://www.fmcv.com.
About Fresenius Medical Care:
Fresenius Medical Care is the world's largest provider of products and services for individuals with renal diseases of which around 3.2 million patients worldwide regularly undergo dialysis treatment. Through its network of 3,872 dialysis clinics, Fresenius Medical Care provides dialysis treatments for 329,085 patients around the globe. Fresenius Medical Care is also the leading provider of dialysis products such as dialysis machines or dialyzers. Along with its core business, the company provides related medical services in the field of Care Coordination. Fresenius Medical Care is listed on the Frankfurt Stock Exchange (FME) and on the New York Stock Exchange (FMS).